ArticleClinical rheumatology2026
Association between the systemic immune-inflammation index and risk of osteoarthritis: a cross-sectional NHANES 2013-2018 study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA well-known global public health issue, osteoarthritis (OA) primarily affects the elderly. Although the etiology of OA remains unknown, immune and inflammatory factors are considered nonnegligible risk factors. This study investigated the association between the systemic immune-inflammatory index (SII) and the risk of OA.
methodsBased on data from the National Health and Nutrition Examination Survey (NHANES), laboratory testing, basic information, and questionnaires were collected for cross-sectional analysis from a total of 15,317 adults during 2013-2018. In this study, the exposure variable was systemic inflammatory status as defined by SII, and the outcome was OA. Due to the complex survey design and sample weighting, we employed multiple logistic regression models and stratified analyses to evaluate the association between SII and OA. In addition, using an interaction test, we examined the relationship between SII, OA, and other variables.
resultsThis study included a total of 15,317 participants, of whom 2207 were diagnosed with OA. Compared with the non-OA group, participants in the OA group had a significantly higher SII level. After adjusting for all covariates, log SII was positively associated with OA prevalence (OR = 1.27, 95% CI: 1.02, 1.59, P = 0.0353). Participants in the fourth SII quartile had a significantly higher OA prevalence than those in the first quartile (OR = 1.18, 95% CI: 1.00, 1.39, P = 0.0454). Subgroup analyses further confirmed the robustness of this positive association.
conclusionOur study demonstrated that SII was associated with the risk of OA, suggesting a complex correlation between immunity and inflammation in OA. SII may serve as a useful predictor of OA and offer new insights into the diagnosis and management of the condition. Key Points • Elevated systemic immune-inflammatory index (SII) is significantly associated with a higher prevalence of osteoarthritis in a large, representative US adult population. • This positive association persists after comprehensive adjustment for potential confounders and across diverse population subgroups. • SII, as a novel and integrated biomarker, may offer valuable insights for the prediction and management of osteoarthritis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.